Академический Документы
Профессиональный Документы
Культура Документы
Exide Industries
Lower staff cost leads to margin beat Rating: Buy
In-line revenue led by auto replacement growth Target Price: INR 290
Upside: 35%
Exide Industries (EXID IN) revenue grew 6% YoY to INR 26bn, in line
CMP: INR 214 (as on 30 April 2019)
with our estimates, led by automotive replacement, UPS, solar & other
Global Markets Research
infrastructure segments. EBITDA grew 10% YoY to INR 3.7bn, 5% Key data
ahead of our estimates, while margin increased 60bp YoY & 180bp Bloomberg /Reuters Code EXID IN/EXID.BO
QoQ to 14.4%, 70bp above our estimates. Other expenses dipped by Current /Dil. Shares O/S (mn) 850/850
3% QoQ and employee cost declined 10% QoQ despite 4% QoQ Mkt Cap (INR bn/USD mn) 182/2,614
revenue growth, which resulted in margin beat. The RMC-sales ratio Daily Vol. (3M NSE Avg.) 2,371,132
remains flat QoQ to 64.9%. A lower-than-estimated tax rate resulted in Face Value (INR) 1
1 USD = INR 70
PAT growth of 11% YoY to INR 2.1bn, 13% ahead of our estimates.
Note: *as on 30 April 2019; Source: Bloomberg
Strong automotive replacement demand, to sustain in FY20
Price & Volume
Demand in the automotive replacement segment remains robust, led
350 20
by Dynex as well as core Exide brand, according to our channel checks
while the auto OEM segment might decline for another quarter before 300 15
recovering from Q2. While auto replacement growth has been robust 250 10
in FY19, it has slowed in Q4; we are monitoring it.
200 5
Valuation: reiterate Buy with a revised TP of INR 290
150 0
Apr-18 Jul-18 Oct-18 Jan-19 Apr-19
Exide’s revenue growth at 15% YoY in FY19 continues to be strong and
the benefits of stable replacement growth would aid the company to post Vol. in mn (RHS) Exide Industries (LHS)
resilient revenue CAGR of ~11% over FY20-21E despite likely pressures in Source: Bloomberg
the auto OEM segment. The inverter battery segment, while cyclical in Share holding (%) Q1FY19 Q2FY19 Q3FY19 Q4FY19
nature, is expected to be partially offset by the ramp-up in solar power and Promoter 46.0 46.0 46.0 46.0
motive power batteries. Mr. Gautam Chatterjee being reappointed as MD Institutional Investors 34.4 34.6 34.2 33.8
and CEO for a period of 2 years from May 1st 2019 is a positive, as he was Other Investors 9.1 9.3 9.8 10.0
General Public 10.5 10.1 10.1 10.3
instrumental in turning around Exide’s performance. Our channel checks
Source: BSE
suggest April 2019 has started on a positive note for inverter battery
segment sales (crucial segment in Q1 of any fiscal). Lead prices also have Price performance (%) 3M 6M 12M
softened, which should boost margin in the near term. We reduce our Sensex 8.4 17.1 12.5
Exide Industries (6.8) (14.8) (11.9)
FY20-21E EPS by 7-8% to factor in revenue, primarily led by the auto OEM
Source: Bloomberg
& industrial segments and margin cuts. We recommend Buy with a new
SOTP-based TP of INR 290 from INR 302 on 20x (unchanged) FY21E P/E
and 2x EV of the insurance business.
YE March (INR mn) Q4FY19 Q4FY18 YoY (%) Q3FY19 QoQ (%) Q4FY19E Variance (%)
Revenue 25,987 24,594 5.7 24,968 4.1 26,070 (0.3)
Operating costs 22,254 21,214 4.9 21,843 1.9 22,515 (1.2)
EBITDA 3,733 3,380 10.4 3,125 19.4 3,555 5.0
EBITDA margin (%) 14.4 13.7 62 12.5 184.6 13.6 73
Depn & amort. 835 674 23.8 813 2.6 850 (1.8)
EBIT 2,898 2,706 7.1 2,312 25.3 2,705 7.1
Interest expense 12 6.3 96.8 23 (46.3) 20.0 (38.0)
Other Income 166 203 (18.1) 80 107.8 170 (2.4)
Pretax profit 3,051 2,903 5.1 2,369 28.8 2,855 6.9
Tax 945 1,007 (6.2) 818 15.4 985 (4.1)
Tax rate (%) 31.0 34.7 34.5 (359.5) 34.5 (10.3)
Adjusted Net profit 2,107 1,896 11.1 1,550 35.9 1,870 12.7
Exceptionals 0 0 0 0
Reported Net Profit 2,107 1,896 11.1 1,550 35.9 1,870 12.7
EPS (INR) 2.5 2.2 11.1 1.8 35.9 2.2 12.7
Key Financials
EBITDA
YE Rev YoY EBITDA Adj PAT YoY Fully DEPS RoE RoCE P/E EV/EBITDA
margin
March (INR mn) (%) (INR mn) (INR mn) (%) (INR) (%) (%) (x) (x)
(%)
FY18 91,863 21.1 12,408 13.5 7,102 2.4 8.4 13.7 20.0 26.3 15.0
FY19 105,883 15.3 14,113 13.3 7,358 3.6 8.7 12.9 20.0 25.4 13.2
FY20E 117,468 10.9 16,211 13.8 8,908 21.1 10.5 14.1 20.8 21.0 11.5
FY21E 129,530 13.2 18,350 14.2 10,198 14.5 12.0 14.6 21.3 18.3 10.1
Note: pricing as on 30 April 2019; Source: Company, Elara Securities Estimate
Jay Kale, CFA • jay.kale@elaracapital.com • +91 22 6164 8507
Vijay Gyanchandani • vijay.gyanchandani@elaracapital.com • +91 22 6164 8511
Elara Securities (India) Private Limited
Exide Industries
(INR mn)
13.3
(%)
Less :- Depreciation & Amortization 2,459 3,135 3,488 3,786 100,000 13.5
EBIT 10,532 11,363 13,154 15,047
80,000 13.0
Less:- Interest Expenses 52 61 54 49
PBT 10,480 11,303 13,100 14,997
60,000 12.5
Less :- Taxes 3,378 3,945 4,192 4,799 FY18 FY19 FY20E FY21E
Adjusted PAT 7,102 7,358 8,908 10,198 Net Revenues EBITDA Margin
Add/Less: - Extra-ordinaries (418) 1,083 - -
Source: Company, Elara Securities Estimate
Reported PAT 6,683 8,440 8,908 10,198
Balance Sheet (INR mn) FY18 FY19 FY20E FY21E
Share Capital 850 850 850 850
Adjusted profit growth trend
Reserves 53,043 59,020 65,342 72,954
Net worth 53,893 59,870 66,192 73,804 12,000 21.1 25
Borrowings 0 0 500 500 10,000 20
Deferred Tax (Net) 1,405 1,751 2,013 2,313 8,000
14.5
(INR mn)
Other liabilities 7,884 8,627 8,627 8,627 15
(%)
6,000
Total Liabilities 63,182 70,248 77,332 85,245 10
4,000
Gross Block 25,106 31,864 35,864 39,864 3.6
2.4 5
2,000
Less:- Accumulated Depreciation 5,756 8,891 12,379 16,165
0 0
Net Block 19,350 22,973 23,485 23,698
FY18 FY19 FY20E FY21E
Add:- Capital work in progress 2,569 2,549 2,549 2,549
Adjusted PAT PAT Growth
Investments 19,690 21,994 25,994 29,994
Net Working Capital 16,248 17,376 19,861 21,900 Source: Company, Elara Securities Estimate
Cash and Cash Equivalents 872 736 758 2,341
Other Assets 4,453 4,621 4,685 4,762
Total Assets 63,182 70,248 77,332 85,245 Return ratios
Cash Flow Statement (INR mn) FY18 FY19 FY20E FY21E
22 20.8 21.3
Cash profit adjusted for non cash items 8,991 11,937 12,658 14,285 20.0 20.0
Add/Less : Working Capital Changes (1,741) (384) (2,485) (2,039) 20
Exhibit 1: Revenue growth YoY moderates to single Exhibit 2: EBITDA growth impressive in Q4 due to
digit post Q2 lower operating costs
30,000 40 5,000 40
25,000 4,000 30
30
20,000
(INR mn)
(INR mn)
3,000 20
(%)
(%)
15,000 20
2,000 10
10,000
10
5,000 1,000 0
0 0 0 (10)
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Q3FY18
Q4FY18
Q1FY19
Q2FY19
Q3FY19
Q4FY19
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Q3FY18
Q4FY18
Q1FY19
Q2FY19
Q3FY19
Q4FY19
Auto Ancillaries
Revenue YoY growth EBIDTA YoY growth
Source: Company, Elara Securities Research Source: Company, Elara Securities Research
Exhibit 3: Lead prices trend Exhibit 4: Exide's V/s Amara Raja's margin trend
2,700 18
2,500
16
(USD/tonne)
2,300
14
(%)
2,100
1,900 12
1,700 10
Q3FY18
Q4FY19
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Q4FY18
Q1FY19
Q2FY19
Q3FY19
1,500
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Q3FY18
Q4FY18
Q1FY19
Q2FY19
Q3FY19
Q4FY19
Source: Company, Elara Securities Research Source: Company, Elara Securities Research
66 2,000 30
(%)
(INR mn)
64 1,500 20 (%)
62 1,000 10
60 500 0
58 0 (10)
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Q3FY18
Q4FY18
Q1FY19
Q2FY19
Q3FY19
Q4FY19
56
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Q3FY18
Q4FY18
Q1FY19
Q2FY19
Q3FY19
Q4FY19
Source: Company, Elara Securities Research Source: Company, Elara Securities Research
Exhibit 7: Valuation
FY21E
Core EPS (INR) 12.1
Multiple (x) 20.0
2x BV Exide Life Insurance business value
47
(INR)
SOTP-based TP (INR) 290
CMP (INR) 214
Potential upside (%) 35
Note: pricing as on 30 April 2019; Source: Elara Securities Estimate
Coverage History
350
300
13
250 8 14
12
15
7 11
6 9
200 10 16 17
5
Auto Ancillaries
1 2
150 4
3
100
May-15
May-16
May-17
May-18
Sep-15
Sep-16
Sep-17
Sep-18
Jan-15
Nov-15
Jan-16
Nov-16
Jan-17
Nov-17
Jan-18
Nov-18
Jan-19
Jul-15
Jul-16
Jul-17
Jul-18
Mar-15
Mar-16
Mar-17
Mar-18
Mar-19
Not Covered Covered
Any clarifications / queries on the proposal as well as any future communication regarding the proposal should be addressed to Elara Securities (India) Private
Limited.
Elara Securities (India) Private Limited was incorporated in July 2007 as a subsidiary of Elara Capital (India) Private Limited.
Elara Securities (India) Private Limited is a SEBI registered Stock Broker in the Capital Market and Futures & Options Segments of National Stock Exchange of India
Limited [NSE], in the Capital Market Segment of BSE Limited [BSE] and a Depository Participant registered with Central Depository Services (India) Limited [CDSL].
Elara Securities (India) Private Limited’s business, amongst other things, is to undertake all associated activities relating to its broking business.
The activities of Elara Securities (India) Private Limited were neither suspended nor has it defaulted with any stock exchange authority with whom it is registered in
last five years. However, during the routine course of inspection and based on observations, the exchanges have issued advise letters or levied minor penalties on
Elara Securities (India) Private Limited for minor operational deviations in certain cases. Elara Securities (India) Private Limited has not been debarred from doing
business by any Stock Exchange / SEBI or any other authorities; nor has the certificate of registration been cancelled by SEBI at any point of time.
Elara Securities (India) Private Limited offers research services primarily to institutional investors and their employee s, directors, fund managers, advisors who are
registered or proposed to be registered.
Details of Associates of Elara Securities (India) Private Limited are available on group company website www.elaracapital.com
Elara Securities (India) Private Limited is maintaining arms-length relationship with its associate entities.
Research Analyst or his/her relative(s) may have financial interest in the subject company. Elara Securities (India) Private Limited does not have any financial
interest in the subject company, whereas its associate entities may have financial interest. Research Analyst or his/her relative does not have actual/beneficial
ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research Report. Elara
Securities (India) Private Limited does not have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately
preceding the date of publication of Research Report. Associate entities of Elara Securities (India) Private Limited may have actual/beneficial ownership of 1% or
more securities of the subject company at the end of the month immediately preceding the date of publication of Research Report. Research Analyst or his/her
relative or Elara Securities (India) Private Limited or its associate entities does not have any other material conflict of interest at the time of publication of the
Research Report.
Research Analyst or his/her relative(s) has not served as an officer, director or employee of the subject company.
Research analyst or Elara Securities (India) Private Limited have not received any compensation from the subject company in the past twelve months. Associate
entities of Elara Securities (India) Private Limited may have received compensation from the subject company in the past twelve months. Research analyst or Elara
Securities (India) Private Limited or its associate entities have not managed or co-managed public offering of securities for the subject company in the past twelve
months. Research analyst or Elara Securities (India) Private Limited or its associates have not received any compensation for investment banking or merchant
banking or brokerage services from the subject company in the past twelve months. Research analyst or Elara Securities (India) Private Limited or its associate
entities may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject
company or third party in connection with the Research Report in the past twelve months.
6
Elara Securities (India) Private Limited
The information contained in this note is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although
we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will
continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the
particular situation.
Elara Capital Inc.’s affiliate did not manage an offering for Exide Industries Limited.
Elara Capital Inc.’s affiliate did not receive compensation from Exide Industries Limited in the last 12 months.
Elara Capital Inc.’s affiliate does not expect to receive compensation from Exide Industries Limited in the next 3 months.
This material is based upon information that we consider to be reliable, but Elara Capital Inc. does not warrant its completeness, accuracy or adequacy and it
should not be relied upon as such.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities, financial instruments or
strategies mentioned herein may not be suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice,
and are only correct as of the stated date of their issue. Prices, values or income from any securities or investments mentioned in this report may fall against the
interests of the investor and the investor may get back less than the amount invested. Where an investment is described as being likely to yield income, please
note that the amount of income that the investor will receive from such an investment may fluctuate. Where an investment or security is denominated in a
different currency to the investor’s currency of reference, changes in rates of exchange may have an adverse effect on the value, price or income of or from that
investment to the investor. The information contained in this report does not constitute advice on the tax consequences of making any particular investment
decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation
of particular securities, financial instruments or strategies to you. Before acting on any recommendation in this material, you should consider whether it is
suitable for your particular circumstances and, if necessary, seek professional advice.
Certain statements in this report, including any financial projections, may constitute “forward-looking statements.” These “forward-looking statements” are not
guarantees of future performance and are based on numerous current assumptions that are subject to significant uncertainties and contingencies. Actual
future performance could differ materially from these “forward-looking statements” and financial information.
7
Elara Securities (India) Private Limited
Ravi Sundar Muthukrishnan Ph.D Head - Institutional Equity Research ravi.muthukrishnan@elaracapital.com +91 22 6164 8572
Research
Akhil Parekh Analyst Midcap akhil.parekh@elaracapital.com +91 22 6164 8519
Ankita Shah Analyst Infrastructure, Ports & Logistics ankita.shah@elaracapital.com +91 22 6164 8516
Biju Samuel Analyst Quantitative & Alternate Strategy biju.samuel@elaracapital.com +91 22 6164 8505
Gagan Dixit Analyst Oil & Gas, Aviation gagan.dixit@elaracapital.com +91 22 6164 8504
Garima Kapoor Economist garima.kapoor@elaracapital.com +91 22 6164 8527
Harshit Kapadia Analyst Capital Goods harshit.kapadia@elaracapital.com +91 22 6164 8542
Karan Taurani Analyst Media & Entertainment karan.taurani@elaracapital.com +91 22 6164 8513
Jay Kale, CFA Analyst Auto & Auto Ancillaries jay.kale@elaracapital.com +91 22 6164 8507
Param Desai Analyst Pharmaceuticals, Healthcare, Real Estate param.desai@elaracapital.com +91 22 6164 8528
Pradeep Kumar Kesavan, CFA Analyst Strategy pradeep.kesavan@elaracapital.com +91 22 6164 8541
Pratik Tholiya Analyst Agrochemicals, Travel & Hospitality pratik.tholiya@elaracapital.com +91 22 6164 8518
Rakesh Kumar Analyst Banking & Financials rakesh.kumar@elaracapital.com +91 22 6164 8559
Ravi Menon Analyst IT Services, Internet, Telecom ravi.menon@elaracapital.com +91 22 6164 8502
Ravi Sodah Analyst Cement, Building Materials ravi.sodah@elaracapital.com +91 22 6164 8517
Ritika Dua Analyst Diversified Financials ritika.dua@elaracapital.com +91 22 6164 8526
Rupesh Sankhe Analyst Utilities, Renewables, Capital Goods rupesh.sankhe@elaracapital.com +91 22 6164 8581
Sagarika Mukherjee Analyst FMCG, Dairy sagarika.mukherjee@elaracapital.com +91 22 6164 8594
Saurabh Mitra Sr. Associate Cement, Building Materials saurabh.mitra@elaracapital.com +91 22 6164 8546
Aarti Rao Associate Pharmaceuticals, Healthcare, Real Estate aarti.rao@elaracapital.com +91 22 6164 8535
Anushka Chhajed Associate Strategy anushka.chhajed@elaracapital.com +91 22 6164 8536
Ashish Agrawal Associate IT Services, Internet, Telecom ashish.agrawal@elaracapital.com +91 22 6164 8573
Chintan Shah Associate Banking & Financials chintan.shah@elaracapital.com +91 22 6164 8521
Jatan Gogri Associate Economics jatan.gogri@elaracapital.com +91 22 6164 8591
Praneet Nikumbh Associate Diversified Financials praneet.nikumbh@elaracapital.com +91 22 6164 8506
Priyanka Trivedi Associate Agrochemicals, Travel & Hospitality priyanka.trivedi@elaracapital.com +91 22 6164 8588
Rachael Alva Associate Oil & Gas, Aviation rachael.alva@elaracapital.com +91 22 6164 8525
Shubham Maheshwari Associate FMCG, Dairy shubham.maheshwari@elaracapital.com +91 22 6164 8562
Vijay Gyanchandani Associate Auto & Auto Ancillaries vijay.gyanchandani@elaracapital.com +91 22 6164 8511
Viren Deshpande Associate Media & Entertainment viren.deshpande@elaracapital.com +91 22 6164 8565
Vinayak Patil Database vinayak.patil@elaracapital.com +91 22 6164 8510
Priyanka Sheth Editor priyanka.sheth@elaracapital.com +91 22 6164 8568
Gurunath Parab Production gurunath.parab@elaracapital.com +91 22 6164 8515
Jinesh Bhansali Production jinesh.bhansali@elaracapital.com +91 22 6164 8537
Access our reports on Bloomberg: Type ESEC <GO> Also available on Thomson & Reuters